Should New Zealand replace its current rules for genetically modified organisms with a new gene technology regime that enables wider use of gene technologies under a regulator and risk-tiering framework?
This omnibus bill establishes a new regulatory regime for gene technology and regulated organisms, creating a gene technology regulator to assess and license their use. It replaces the existing approach to regulating genetically modified organisms with a proportionate, risk-tiered system.
MPs’ arguments for and against the bill
Why support it
Supporters argued the current rules for genetically modified organisms are among the most restrictive in the world and have left New Zealand behind countries such as Australia, Canada, and England.
Supporters said a proportionate, outcomes-based regime would let scientists move technologies out of the lab and give farmers and patients access to productivity tools, emissions-reduction methods, and treatments such as CAR T-cell therapy if they choose to use them.
Supporters argued the bill recognises comparable overseas regulators to make better use of international expertise and free up the new regulator's limited resources, while retaining public input and a ban on genetic engineering of human embryos.
Why oppose it
Opponents argued the bill goes further than other countries by leaving SDN-2 processes unregulated when nations like Australia regulate beyond SDN-1, putting New Zealand ahead of others without alignment.
Opponents said there was no broad public consultation and no full economic analysis, citing a New Zealand Institute of Economic Research estimate that export effects could be in the order of $10 billion to $20 billion a year and added certification costs for GMO-free producers.
Opponents argued the bill lacks a certain role for tangata whenua and ethics input, noting the Māori advisory committee need not be consulted and concerns about Treaty obligations and Wai 262.
These are claims MPs made in Parliament’s debate — not verified facts.
Full bill summary & link to official bill page
An omnibus bill that would overhaul how New Zealand regulates gene technology — genetic modification (GMOs) and newer 'gene editing,' where an organism's DNA is deliberately altered. It replaces the strict current regime (under which the Environmental Protection Authority must approve almost any use of a GMO outside the lab) with a new independent Gene Technology Regulator that assesses and licenses uses on a risk-tiered basis: low-risk activities face little red tape, higher-risk ones need full assessment.
Modelled on Australia's system, it aims to make medical and agricultural research and field trials easier. Supporters say it enables climate-resilient crops and medical breakthroughs and brings NZ into line with other countries; critics — including organic and 'GE-free' producers and some Māori — warn of contamination risks to exports and say Treaty of Waitangi protections are reduced to an advisory role.